| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5702720 | Urologic Oncology: Seminars and Original Investigations | 2017 | 8 Pages |
Abstract
Henceforth, this study infer that, hTERT expression can be used as a possible diagnostic marker for RCC, and inhibition of hTERT expression by hampering ERK-mitogen activated protein kinase cascade may be used as a promising anticancer target in RCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Deeksha Ph.D., Ujjawal Ph.D., Shrawan Kumar M.Ch., Nandita M.D., Rajendra Ph.D.,